Neuland Laboratories Ltd (NEUL)

Currency in INR
14,405.00
-572.00(-3.82%)
Closed·
NEUL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
14,283.0015,087.00
52 wk Range
10,578.0019,747.00
Key Statistics
Bid/Ask
14,405.00 / 14,426.00
Prev. Close
14,977
Open
14,900
Day's Range
14,283-15,087
52 wk Range
10,578-19,747
Volume
28.16K
Average Volume (3m)
44.73K
1-Year Change
10.1384%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NEUL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry

Neuland Laboratories Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Employees
1794
Market
India

Compare NEUL to Peers and Sector

Metrics to compare
NEUL
Peers
Sector
Relationship
P/E Ratio
103.2x41.5x−0.5x
PEG Ratio
−2.560.910.00
Price/Book
11.4x4.3x2.6x
Price / LTM Sales
11.7x3.9x3.2x
Upside (Analyst Target)
29.5%9.2%47.4%
Fair Value Upside
Unlock−7.4%7.7%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Goldman Sachs
Buy17,325.00+20.27%18,800.00MaintainFeb 09, 2026
Goldman Sachs
Buy19,700.00+36.76%17,225.00MaintainNov 09, 2025
Goldman Sachs
Buy17,225.00+19.58%15,425.00MaintainOct 14, 2025
Goldman Sachs
Buy15,750.00+9.34%14,775.00MaintainJul 15, 2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 139.62%
Dividend Yield
0.08%
Industry Median 0.76%
Annualized payout
12.00
Paid annually
5-Years Growth
+43.10%
Growth Streak

Earnings

Latest Release
Feb 09, 2026
EPS / Forecast
37.00 / 85.10
Revenue / Forecast
4.4B / 4.74B
EPS Revisions
Last 90 days

NEUL Income Statement

People Also Watch

20,347.00
FORC
-1.94%
736.10
JYCA
-2.46%
1,024.95
SAIE
-1.60%
7,570.00
CRAF
-2.33%
512.750
ELCN
0.00%

FAQ

What Is the Neuland Laboratories (NEUL) Stock Price Today?

The Neuland Laboratories stock price today is 14,405.00 INR.

What Stock Exchange Does Neuland Laboratories Trade On?

Neuland Laboratories is listed and trades on the India National Stock Exchange.

What Is the Stock Symbol for Neuland Laboratories?

The stock symbol for Neuland Laboratories is "NEUL."

Does Neuland Laboratories Pay Dividends? What’s The Current Dividend Yield?

The Neuland Laboratories dividend yield is 0.08%.

What Is the Neuland Laboratories Market Cap?

As of today, Neuland Laboratories market cap is 184.87B INR.

What Is Neuland Laboratories's Earnings Per Share (TTM)?

The Neuland Laboratories EPS (TTM) is 139.62.

When Is the Next Neuland Laboratories Earnings Date?

Neuland Laboratories will release its next earnings report on May 12, 2026.

From a Technical Analysis Perspective, Is NEUL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Neuland Laboratories Stock Split?

Neuland Laboratories has split 2 times.

How Many Employees Does Neuland Laboratories Have?

Neuland Laboratories has 1794 employees.

What is the current trading status of Neuland Laboratories (NEUL)?

As of Apr 26, 2026, Neuland Laboratories (NEUL) is trading at a price of 14,405.00 INR, with a previous close of 14,977.00 INR. The stock has fluctuated within a day range of 14,283.00 INR to 15,087.00 INR, while its 52-week range spans from 10,578.00 INR to 19,747.00 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.